Analysis of pathogen and host factors related to clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus

Journal of Clinical Microbiology

Volumn 50, Issue 5, 2012, Pages 1640-1644

  Haque, Nadia Z ^a   Arshad, Samia ^a   Peyrani, Paula ^c   Ford, Kimbal D ^d   Perri, Mary B ^a   Jacobsen, Gordon ^a   Reyes, Katherine ^a   Scerpella, Ernesto G ^d   Ramirez, Julio A ^c   Zervos, Marcus J ^a,b  

^a Henry Ford Health System Division of Infectious Diseases   (United States)

^b WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c University of Louisville School of Medicine   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PANTON VALENTINE LEUKOCIDIN; VANCOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; APACHE; ARTICLE; BACTERIUM ISOLATE; DIABETES MELLITUS; FEMALE; HEART DISEASE; HOSPITAL ACQUIRED PNEUMONIA; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOLECULAR GENETICS; MORTALITY; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; VASCULAR DISEASE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BACTERIAL TOXINS; CROSS INFECTION; EXOTOXINS; FEMALE; GENOTYPE; HUMANS; LEUKOCIDINS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MOLECULAR TYPING; PNEUMONIA, STAPHYLOCOCCAL; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VANCOMYCIN RESISTANCE; VIRULENCE FACTORS; YOUNG ADULT;

EID: 84859945784     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.06701-11     Document Type: Article

References (28)

1. Albur MS, Bowker K, Weir I, Macgowan A. 2011. Factors influencing the clinical outcome of methicillin-resistant Staphylococcus aureus bacteraemia. Eur. J. Clin. Microbiol. Infect. Dis.
2. American Thoracic Society and the Infectious Diseases Society of America. 2005. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am. J. Respir. Crit. Care Med. 171:388-416.
3. Athanassa Z, Siempos II, Falagas ME. 2008. Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review. Eur. Respir. J. 31:625-632.
4. Chua T, et al. 2008. Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit. J. Clin. Microbiol. 46:2345-2352.
5. Combes A, et al. 2007. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia. Crit. Care Med. 35: 146-154. (Pubitemid 46035690)
6. Combes A, et al. 2004. Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 170:786-792. (Pubitemid 39298995)
7. Depuydt PO, et al. 2008. Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia. Crit. Care. 12:R142.
8. Fowler VG, Jr et al. 2004. Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein. J. Infect. Dis. 190:1140-1149.
9. Francis JS, et al. 2005. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin. Infect. Dis. 40:100-107. (Pubitemid 40053465)
10. Gastmeier P, Sohr D, Geffers C, Behnke M, Ruden H. 2007. Risk factors for death due to nosocomial infection in intensive care unit patients: findings from the Krankenhaus Infektions Surveillance System. Infect. Control Hosp. Epidemiol. 28:466-472. (Pubitemid 46658061)
11. Gonzalez BE, et al. 2006. Community-associated strains of methicillin-resistant Staphylococccus aureus as the cause of healthcare-associated infection. Infect. Control Hosp. Epidemiol. 27:1051-1056. (Pubitemid 44670980)
12. Hota B, et al. 2011. Predictors of clinical virulence in community-onset methicillin-resistant Staphylococcus aureus infections: the importance of USA300 and pneumonia. Clin. Infect. Dis. 53:757-765.
13. Klevens RM, et al. 2006. Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors. Emerg. Infect. Dis. 12: 1991-1993. (Pubitemid 44904946)
14. Kollef KE, Reichley RM, Micek ST, Kollef MH. 2008. The modified APACHE II score outperforms Curb65 pneumonia severity score as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus pneumonia. Chest 133:363-369. (Pubitemid 351272393)
15. Lopez-Aguilar C, et al. 2007. Association between the presence of the Panton-Valentine leukocidin-encoding gene and a lower rate of survival among hospitalized pulmonary patients with staphylococcal disease. J. Clin. Microbiol. 45:274-276. (Pubitemid 46106447)
16. Mangino JE, et al. 2011. Development and implementation of a performance improvement project in adult intensive care units: overview of the Improving Medicine Through Pathway Assessment of Critical Therapy in Hospital-Acquired Pneumonia (IMPACT-HAP) study. Crit. Care. 15: R38. Epub 2011 Jan 25.
17. Maree CL, Daum RS, Boyle-Vavra S, Matayoshi K, Miller LG. 2007. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg. Infect. Dis. 13:236-242. (Pubitemid 46193166)
18. Moore CL, et al. 2011. Prediction of failure in vancomycin-treated methicillin- resistant Staphylococcus aureus bloodstream infection: a clinically useful risk stratification tool. Antimicrob. Agents Chemother. 55:4581-4588.
19. Moore CL, et al. 2010. USA600 (ST45) methicillin-resistant Staphylococcus aureus bloodstream infections in urban Detroit. J. Clin. Microbiol. 48:2307-2310.
20. Ott E, et al. 2010. Costs of nosocomial pneumonia caused by meticillin-resistant Staphylococcus aureus. J. Hosp. Infect. 76:300-303.
21. Peyrani P, et al. 2011. Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton- Valentine leukocidin gene. Clin. Infect. Dis. 53:766-771.
22. Popovich KJ, Weinstein RA, Hota B. 2008. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin. Infect. Dis. 46:787-794. (Pubitemid 351417176)
23. Seybold U, et al. 2006. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin. Infect. Dis. 42:647-656. (Pubitemid 43271378)
24. Shorr AF, et al. 2010. Clinical and economic outcomes for patients with health care-associated Staphylococcus aureus pneumonia. J. Clin. Microbiol. 48:3258-3262.
25. Shorr AF, et al. 2006. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit. Care. 10:R97.
26. Tacconelli E, De Angelis G. 2009. Pneumonia due to methicillin-resistant Staphylococcus aureus: clinical features, diagnosis and management. Curr. Opin. Pulm. Med. 15:218-222.
27. Vardakas KZ, Matthaiou DK, Falagas ME. 2009. Comparison of community- acquired pneumonia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus producing the Panton-Valentine leukocidin. Int. J. Tuberc. Lung Dis. 13:1476-1485.
28. Wootton M, et al. 2004. Genetic analysis of 17 genes in Staphylococcus aureus with reduced susceptibility to vancomycin (VISA) and heteroVISA. J. Antimicrob. Chemother. 53:406-407. (Pubitemid 38239988)